Trifluridine/tipiracil plus bevacizumab (FTD/TPI plus BEV) and trifluridine/tipiracil (FTD/TPI) monotherapy in metastatic colorectal cancer (mCRC): Results of a meta-analysis.

Yoshino, T; Taieb, J; Andre, T; Kuboki, Y; Pfeiffer, P; Kumar, A; Hochster, HS

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索